Urology

PSAdynia and other PSA-related syndromes: a new epidemic--a case history and taxonomy
pp. 831-832(2)
Author: Klotz L.H.

Cancer of the prostate: a nutritional disease?
pp. 840-848(9)
Authors: Fair W.R.; Fleshner N.E.; Heston W.

Initial experience with extraperitoneal endoscopic radical retropubic prostatectomy
pp. 849-853(5)
Authors: Raboy A.; Ferzli G.; Albert P.

Laparoscopic radical prostatectomy: initial short-term experience
pp. 854-857(4)
Authors: Schuessler W.W.; Schulam P.G.; Clayman R.V.; Kavoussi L.R.

Factitious renal colic
pp. 858-862(5)
Authors: Reich J.D.; Hanno P.M.

Treatment of renal cell carcinoma with 5-fluorouracil and alfa-interferon
pp. 863-868(6)
Authors: Gebrosky N.P.; Koukol S.; Nseyo U.O.; Carpenter C.; Lamm D.L.

Grading of upper urinary tract transitional cell carcinoma by computed DNA content and p53 expression
pp. 869-874(6)
Authors: Minimo C.; Tawfiek E.R.; Bagley D.H.; McCue P.A.; Bibbo M.

Holmium:YAG laser endoureterotomy for treatment of ureteral stricture
pp. 875-880(6)
Authors: Singal R.K.; Denstedt J.D.; Razvi H.A.; Chun S.S.

Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors
pp. 882-887(6)
Authors: Ellis W.J.; Blumenstein B.A.; Ishak L.M.; Enfield D.L.

Vitamin B₁₂ and folic acid plasma levels after ileocecal and ileal neobladder reconstruction
pp. 888-892(5)
Authors: Racioppi M.; D'Addessi A.; Fanasca A.; Mingrone G.; Benedetti G.; Capristo E.; Maussier M.L.; Valenza V.; Alcini A.; Alcini E.

Autoimmune prostatitis: evidence of T cell reactivity with normal prostatic proteins
pp. 893-899(7)
Authors: Alexander R.B.; Brady F.; Ponniah S.

Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting
pp. 901-905(5)
Authors: Keetch D.W.; Andriole G.L.; Ratliff T.L.; Catalona W.J.

Color doppler imaging in predicting the biologic behavior of prostate cancer: correlation with disease-free survival
pp. 906-912(7)
Authors: Ismail M.; Petersen R.O.; Alexander A.A.; Newschaffer C.; Gomella L.G.

Daily dosing with flutamide or Casodex exerts maximal antiandrogenic activity
pp. 913-919(7)
Authors: Luo S.; Martel C.; Chen C.; Labrie C.; Candas B.; Singh S.M.; Labrie F.

Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument
pp. 920-928(9)
Authors: Esper P.; Mo F.; Chodak G.; Sinner M.; Cella D.; Pienta K.J.

Tamoxifen for flutamide/finasteride-induced gynecomastia
pp. 929-933(5)
Authors: Staiman V.R.; Lowe F.C.

Pelvic floor electrical stimulation for the treatment of urge and mixed urinary incontinence in women
pp. 934-940(7)
Authors: Siegel S.W.; Richardson D.A.; Miller K.L.; Karram M.M.; Blackwood N.B.; Sand P.K.; Staskin D.R.; Tuttle J.P.

Correlation of urodynamic results and urethral coaptation with success after transurethral collagen injection
pp. 941-948(8)
Authors: Kim Y.H.; Kattan M.W.; Boone T.B.

Study of the effect of external urethral sphincter contraction on the mechanical activity of the ureterovesical junction and urinary bladder: recognition of the sphinctero-ureterovesical reflex
pp. 949-952(4)
Author: Shafik A.

Color doppler ultrasound criteria to diagnose varicoceles: correlation of a new scoring system with physical examination
pp. 953-956(4)
Authors: Chiou R.K.; Anderson J.C.; Wobig R.K.; Rosinsky D.E.; Matamoros A.; Chen W.S.; Taylor R.J.

Postchemotherapy retroperitoneal lymph node dissection is effective therapy in selected patients with elevated tumor markers after primary chemotherapy alone
pp. 957-962(6)
Authors: Coogan C.L.; Foster R.S.; Rowland R.G.; Bihrle R.; Smith E.R.; Einhorn L.H.; Roth B.J.; Donohue J.P.

Pediatric pyeloplasty: outcome analysis based on patient age and surgical technique
pp. 963-966(4)
Authors: Sutherland R.W.; Chung S.-K.; Roth D.R.; Gonzales E.T.

Long-term nutritional consequences of bowel segment use for lower urinary tract reconstruction in pediatric patients
pp. 967-971(5)
Authors: Kalloo N.B.; Jeffs R.D.; Gearhart J.P.

Progessive angiomyolipoma with inferior vena cava tumor thrombus
pp. 975-977(3)
Authors: Bernstein M.R.; Malkowicz S.B.; Siegelman E.S.; Acker M.; Tomaszewski J.E.; Wein A.J.

Long survival of a patient with paratesticular rhabdomyosarcoma with inferior vena cava involvement
pp. 978-979(2)
Authors: Rodriguez-Rubio F.I.; Abad J.I.; Rabago G.; Berian J.M.

Blastomycosis of the epididymis and prostate
pp. 980-982(3)
Authors: Seo R.; Oyasu R.; Schaeffer A.

Prostatic urethral strictures after transurethral microwave thermal therapy for benign prostatic hyperplasia
pp. 983-985(3)
Authors: Sall M.; Bruskewitz R.C.

Transperineal radiofrequency interstitial tumor ablation of the prostate: correlation of magnetic resonance imaging with histopathologic examination
pp. 986-993(8)
Authors: Djavan B.; Zlotta A.R.; Susani M.; Heinz G.; Shariat S.; Silverman D.E.; Schulman C.C.; Marberger M.

Evaluation of a no-needle penile injector: a preliminary study evaluating tissue penetration and its hemodynamic consequences in the rat
pp. 994-998(5)
Authors: Seyam R.M.; Begin L.R.; Mai Tu L.; Dion S.B.; Merlin S.L.; Brock G.B.

Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the dunning rat prostate model system
pp. 999-1006(8)
Authors: Getzenberg R.H.; Light B.W.; Lapco P.E.; Konety B.R.; Nangia A.K.; Acierno J.S.; Dhir R.; Shurin Z.; Day R.S.; Trump D.L.; Johnson C.S.

Antiproliferative effects of c-myc antisense oligonucleotide in prostate cancer cells: a novel therapy in prostate cancer
pp. 1007-1015(9)
Authors: Balaji K.C.; Koul H.; Mitra S.; Maramag C.; Reddy P.; Menon M.; Malhotra R.K.; Laxmanan S.

Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS
pp. 1016-1026(11)
Authors: Seftel A.D.; Vaziri N.D.; Ni Z.; Razmjouei K.; Fogarty J.; Hampel N.; Polak J.; Wang R.-Z.; Ferguson K.; Block C.; Haas C.